NYSE American - Delayed Quote USD

Cryo-Cell International, Inc. (CCEL)

7.80 -0.07 (-0.89%)
At close: April 25 at 4:00 PM EDT
12.47 +4.67 (+59.87%)
After hours: April 25 at 7:33 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. David I. Portnoy Chairman & Co-CEO 1.45M -- 1963
Mr. Mark L. Portnoy Co-CEO & Director 990k -- 1964
Ms. Jill M. Taymans CFO & VP of Finance 254.77k -- 1970
Mr. Oleg Mikulinsky Chief Information Officer 382.77k -- 1973
Dr. Joanne Kurtzberg M.D. Medical Director and Member of Medical & Scientific Advisory Board -- -- --

Cryo-Cell International, Inc.

700 Brooker Creek Boulevard
Suite 1800
Oldsmar, FL 34677
United States
813 749 2100 https://www.cryo-cell.com
Sector: 
Healthcare
Full Time Employees: 
82

Description

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Corporate Governance

Cryo-Cell International, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

Jul 12, 2024 - Jul 16, 2024
Cryo-Cell International, Inc. Earnings Call

Related Tickers

AMS American Shared Hospital Services
3.1200
+3.31%
 
AIRS AirSculpt Technologies, Inc.
5.52
-1.95%
 
HWAIF Healwell AI Inc.
1.1200
+3.23%
 
TOI The Oncology Institute, Inc.
1.1800
-1.67%
 
CCRN Cross Country Healthcare, Inc.
17.40
-0.97%
 
MODV ModivCare Inc.
23.93
-3.66%
 
DCGO DocGo Inc.
3.4900
-0.85%
 
LFST LifeStance Health Group, Inc.
6.16
-0.16%
 
BACK IMAC Holdings, Inc.
5.10
+46.34%
 
AGL agilon health, inc.
5.13
-3.75%